Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.

A group of 54 patients with rheumatoid arthritis (31 fast, 23 slow acetylators) treated with sulphasalazine 3 g/day were studied retrospectively. At 24 weeks no difference in the efficacy of the drug could be shown between fast and slow acetylators. In a second prospective study 40 fast acetylators...

Повний опис

Бібліографічні деталі

Опубліковано в::	Ann Rheum Dis
Автори:	Pullar, T, Hunter, J A, Capell, H A
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMJ Publishing Group 1985
Предмети:	Research Article
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2867746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.44.12.831
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!